Capital Analysts, LLC Myriad Genetics Inc Transaction History

Capital Analysts, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$24.13 - $32.63 $4,826 - $6,526	-200 Reduced 50.0%	200 $6,000
Q1 2021 May 17, 2021	BUY	$19.92 - $31.6 $7,968 - $12,640	400 New	400 $12,000
Q4 2020 Feb 16, 2021	SELL	$12.16 - $19.77 $2,432 - $3,954	-200 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$28.45 - $37.14 $34,509 - $45,050	-1,213 Reduced 85.85%	200 $7,000
Q4 2017 Feb 12, 2018	BUY	$28.45 - $37.14 $40,199 - $52,478	1,413	1,413 $92,000

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Analysts, LLC with notifications on news.